44O Updated results from a phase I study evaluating the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rojas, CI
  • Lugowska, I
  • Juergens, Rosalyn
  • Sacher, A
  • Weindler, S
  • Sendur, MAN
  • Dziadziuszko, R
  • Pal, A
  • Alvarez, E Castanon
  • Ahern, ES
  • Lakhani, N
  • Chen, L
  • Jemielita, T
  • Choi, SY
  • Stathis, A

publication date

  • February 2024